Dr. Aftab Bhatti
Consultant Urological Surgeon
Tawam Hospital
United Arab Emirates
Dr. Aftab Bhatti
Consultant Urological Surgeon , Tawam Hospital | United Arab Emirates
Dr Aftab Ahmad Bhatti joined Tawam Hospital as a Consultant Urological Surgeon, after working in the United Kingdom for more than 25 years. The main focus of his work is Urological Oncology, Minimally Invasive Robotic Surgery and Laparoscopic surgery. Dr Aftab A Bhatti graduated from the University of Punjab, Rawalpindi Medical College, Pakistan. He completed his higher urological training from the Northern Deanery, Newcastle upon Tyne, UK. Dr Aftab Bhatti has published over 40 peer reviewed publications and his area of research interest includes kidney and prostate cancer. the area of his interest includes active surveillance for the low risk prostate cancer, surgical anatomy of prostate, refinements to surgical techniques for robotic assisted radical prostatectomy and surgical outcomes of the high risk prostate cancer and prognostic markers for the kidney cancer
Sessions by this speaker
Sunday, 2024-06-30
Session 6: Genitourinary Cancers
11:15 - 14:30
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
Panel Discussion and Q&A
12:25 - 13:00
Prof. Ernest Luiten
Chief Breast Surgery Department
Tawam Hospital
United Arab Emirates
Prof. Ernest Luiten
Chief Breast Surgery Department , Tawam Hospital | United Arab Emirates
Doctor Ernest J.T. Luiten (MD PhD) is a Dutch board certified General and Oncologic surgeon with more than 27 years of experience as a consultant surgeon and a former board member of the Dutch Oncologic Surgical Society. He is specialized in breast cancer surgery with special interest in oncoplastic breast conserving procedures, innovative axillary surgery as well as genetic expression profiling. Doctor Luiten is (co-)author of up to 70 publications in international medical journals and principal investigator of several large multi-center RCT’s including the recently finished RISAS study (PMID: 28487053). Besides that he is also member of the Medical Service of the Automobile Club of Monaco for more than 20 years and involved with the Grand Prix Formula One of Monaco.He recently moved to Abu Dhabi UAE to join the medical staff of the Tawam Hospital in Al Ain.
Sessions by this speaker
Saturday, 2024-06-29
Session 3: Early Breast Cancer
14:00 - 16:00
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Dr. Saadia Dafalla Eltom Ibrahim
Nuclear Medicine Supervisor
Tawam Hospital
United Arab Emirates
Dr. Saadia Dafalla Eltom Ibrahim
Nuclear Medicine Supervisor , Tawam Hospital | United Arab Emirates
Saadia Dafalla Eltom Ibrahim, MSc. Medical Diagnostic Ulrasound, BSc Radiotherapy and Nuclear Medicine, Nuclear Medicine Supervisor Nuclear Medicine Department - Tawam Hospital.
Sessions by this speaker
Saturday, 2024-06-29
GU Workshop - Theranostics: The future of Prostate cancer treatment is here! (Supported by Novartis)
11:30 - 12:30
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Dr. Khalid Balaraj
Consultant Radiation Oncologist
Tawam Hospital
United Arab Emirates
Dr. Khalid Balaraj
Consultant Radiation Oncologist , Tawam Hospital | United Arab Emirates
Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. Currently, Dr.Khalid Balaraj is a consultant radiation oncologist at Tawam Hospital, UAE.
Sessions by this speaker
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Dr. Jawaher Ansari
Chief of Medical Oncology
Tawam Hospital
United Arab Emirates
Dr. Jawaher Ansari
Chief of Medical Oncology , Tawam Hospital | United Arab Emirates
Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.
Sessions by this speaker
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Saturday, 2024-06-29
GU Workshop - Theranostics: The future of Prostate cancer treatment is here! (Supported by Novartis)
11:30 - 12:30
Friday, 2024-06-28
Oncology Fellowship Masterclass
14:00 - 19:00
Lectures by this speaker
Saturday, 2024-06-29
CAPItello-291 Unlocking TRU potential for (HR)+ mBC (Satellite Symposium by AstraZeneca)
11:00 - 11:20
Saturday, 2024-06-29
Introduction: PSMA PET revolution in prostate cancer | Potential for false positives
11:30 - 11:35
Saturday, 2024-06-29
Case 1- Optimal timing for PSMA RLT therapy
11:45 - 11:50
Saturday, 2024-06-29
Case 3- Predicting response to 177Lu-PSMA-617 therapy
12:15 - 12:20
Friday, 2024-06-28
Welcome And Introductory Remarks
14:20 - 14:30
Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiation Oncology
Tawam Hospital
United Arab Emirates
Dr. Abdulrahman Sulaiman Bin Sumaida
Chief of Radiation Oncology , Tawam Hospital | United Arab Emirates
Dr Abdul Rahman Bin Sumaida is currently chief of Radiation Oncology at Tawam hospital AlAin, UAE. Dr Sumaida did his medical education From Milan University –Italy. He completed Radiation oncology residency training program from the Cape Town University. He did clinical Research fellowship in head and neck and Gastrointestinal malignancies from South Africa. He further completed Fellowship in SRS and SBRT from Halifax Canada. He is currently caring patient with head and neck and breast cancer .He is involved in multiple ongoing research. and he is involved in teaching junior staff, and involved in multiple committees
Sessions by this speaker
Saturday, 2024-06-29
Session 3: Early Breast Cancer
14:00 - 16:00
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Saturday, 2024-06-29
Panel Discussion and Q&A
15:20 - 15:40
Dr. Ali Yousif
Oncology Fellow
Tawam Hospital
United Arab Emirates
Dr. Ali Yousif
Oncology Fellow , Tawam Hospital | United Arab Emirates
Oncology Fellow at Tawam Hospital
Sessions by this speaker
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
Panel Discussion and Q&A
15:20 - 15:30
Dr. Aswatha Ramesh
Consultant in Surgical Oncology and Colorectal Surgery
Tawam Hospital
United Arab Emirates
Dr. Aswatha Ramesh
Consultant in Surgical Oncology and Colorectal Surgery , Tawam Hospital | United Arab Emirates
Dr. Aswatha Ramesh, Consultant in Surgical Oncology and Colorectal Surgery, and member of the Royal College of Surgeons and the Association of Coloproctology of Great Britain and Ireland. He has held various senior positions during his extensive years of expertise, including Chief of General Surgery at Manchester University NHS Hospital. Furthermore, Dr. Ramesh has invested in medical advancement with research focusing on the application of Artificial Intelligence in predicting outcomes of Breast and Colorectal Surgery. Now, he implements his leadership and clinical expertise in collaboration with Tawam Hospital to achieve our quest for the utmost healthcare experience
Sessions by this speaker
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Saturday, 2024-06-29
Session 4: Gastrointestinal Cancers
16:00 - 17:50
Lectures by this speaker
Saturday, 2024-06-29
Panel Discussion and Q&A
17:10 - 17:25
Saturday, 2024-06-29
Primary outcome analysis of the ORCHESTRA trial: A randomized phase III trial of additional tumor debulking to first-line palliative systemic therapy for patients with multiorgan metastatic colorectal cancer.
16:00 - 16:10
Dr. Aydah Awadhi
Consultant Physician
Tawam Hospital
United Arab Emirates
Dr. Aydah Awadhi
Consultant Physician , Tawam Hospital | United Arab Emirates
Dr. Aydah Al Awadhi is a Medical Oncologist and Quality Officer in Oncology at Tawam Hospital. She graduated from the MD Anderson Hematology and Medical Oncology fellowship in 2019. Her main interest is in breast cancer and she published several peer review research articles and multiple book chapters in breast cancer.
Sessions by this speaker
Saturday, 2024-06-29
Session 2: Advanced Breast Cancer
11:00 - 14:00
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Sunday, 2024-06-30
Breast Cancer Workshop 3 - Exploring the potential of ADCs in Breast Cancer (Supported by Gilead)
09:30 - 10:30
Lectures by this speaker
Saturday, 2024-06-29
Panel Discussion and Q&A
12:30 - 12:50
Saturday, 2024-06-29
Escalation in the Era of CDK4/6i + ET for HR+ HER2- eBC: Prognosis-Based Approach (Satellite Symposium by Novartis)
14:40 - 15:00
Saturday, 2024-06-29
Panel Discussion and Q&A
15:20 - 15:40
Dr. Diaeddine Trad
Consultant Medical Oncologist
Tawam Hospital
United Arab Emirates
Dr. Diaeddine Trad
Consultant Medical Oncologist , Tawam Hospital | United Arab Emirates
Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.
Sessions by this speaker
Saturday, 2024-06-29
Session 1: Plenary
09:40 - 11:00
Saturday, 2024-06-29
Session 4: Gastrointestinal Cancers
16:00 - 17:50
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Sunday, 2024-06-30
Breast Cancer Workshop 3 - Exploring the potential of ADCs in Breast Cancer (Supported by Gilead)
09:30 - 10:30
Sunday, 2024-06-30
Lung Cancer Workshop 1 - Targeted therapy for a NSCLC- Focus on ALK Inhibition (Supported by Pfizer)
11:30 - 12:30
Sunday, 2024-06-30
Lung Cancer Workshop 2: Transforming the Current Treatment Paradigm in The Management of EGFRm NSCLC for Better Survival Outcomes (Supported by AstraZeneca)
14:30 - 16:00
Lectures by this speaker
Saturday, 2024-06-29
Panel Discussion and Q&A
10:20 - 10:40
Saturday, 2024-06-29
Panel Discussion and Q&A
17:10 - 17:25
Sunday, 2024-06-30
Setting the new standard in the management of early and locally advanced EGFRm NSCLC
14:30 - 14:40
Sunday, 2024-06-30
Debate Topic: Balancing Innovation and Safety: Navigating the Safety Seas of ADCs in Breast Cancer Treatment Clinical Scenario
10:10 - 10:30
Sunday, 2024-06-30
Targeted Therapy for aNSCLC ALK Inhibition: Start Strong for Front Line Therapy
11:30 - 11:50
Dr. Emad Anwar Dawoud
Consultant Clinical Oncologist
Tawam Hospital
United Arab Emirates
Dr. Emad Anwar Dawoud
Consultant Clinical Oncologist , Tawam Hospital | United Arab Emirates
Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt . Dr. Dawoud completed his MD, PhD in clinical oncology since 2010, and Federation of Royal Colleague of physician of United Kingdom medical oncology speciality since 2012 and Master Degree in clinical Oncology since 2003. Dr Dawoud has been graduated from the Al Azhar University in Cairo Egypt since 1997 . Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.
Sessions by this speaker
Sunday, 2024-06-30
Session 5: Lung Cancer
09:00 - 11:15
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Saturday, 2024-06-29
Breast Cancer Workshop 1- HER-2 Positive Early Breast Cancer - Optimising Treatment Options (Supported by Roche)
16:00 - 17:00
Sunday, 2024-06-30
Lung Cancer Workshop 1 - Targeted therapy for a NSCLC- Focus on ALK Inhibition (Supported by Pfizer)
11:30 - 12:30
Sunday, 2024-06-30
Lung Cancer Workshop 2: Transforming the Current Treatment Paradigm in The Management of EGFRm NSCLC for Better Survival Outcomes (Supported by AstraZeneca)
14:30 - 16:00
Lectures by this speaker
Saturday, 2024-06-29
A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.
14:00 - 14:10
Sunday, 2024-06-30
Panel Discussion and Q&A
10:25 - 10:55
Saturday, 2024-06-29
Improving Survival Outcomes in 1L HR+ HER2- Aggressive Disease & Visceral Metastasis Patients (Satellite Symposium by Novartis)
12:10 - 12:30
Saturday, 2024-06-29
Panel Discussion and Q&A
12:30 - 12:50
Saturday, 2024-06-29
Panel Discussion and Q&A
15:20 - 15:40
Saturday, 2024-06-29
Introduction
16:00 - 16:05
Saturday, 2024-06-29
Dual Anti-HER2 Blockade in Adjuvant Setting: Evidence and Perceptions
16:25 - 16:30
Sunday, 2024-06-30
Evolving treatment landscape in the management of advanced EGFRm NSCLC
15:00 - 15:15
Sunday, 2024-06-30
Questions and Conclusion
12:20 - 12:30
Dr. Husam Marashi
Consultant Medical Oncologist
Tawam Hospital
United Arab Emirates
Dr. Husam Marashi
Consultant Medical Oncologist , Tawam Hospital | United Arab Emirates
Dr. M Husam Marashi, a dedicated Medicine specialist at Tawam Hospital, with a focus on General Oncology. Dr. Marashi specializes in Breast, GI, and Head & Neck Cancers. His expertise lies in comprehensive oncological care, ensuring patients receive tailored treatment. With a commitment to staying abreast of advancements, Dr. Marashi plays a crucial role in the multidisciplinary approach to cancer treatment. His empathetic approach and specialized knowledge make him an invaluable asset in the field of Medicine, particularly in the challenging realm of oncology.
Sessions by this speaker
Saturday, 2024-06-29
Session 1: Plenary
09:40 - 11:00
Saturday, 2024-06-29
Session 3: Early Breast Cancer
14:00 - 16:00
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Saturday, 2024-06-29
Breast Cancer Workshop 1- HER-2 Positive Early Breast Cancer - Optimising Treatment Options (Supported by Roche)
16:00 - 17:00
Saturday, 2024-06-29
Breast Cancer Workshop 2 - Optimizing Therapeutic Selection and Sequencing Post CDK 4/6 Inhibition (Supported by Menarini Stemline)
17:00 - 18:00
Sunday, 2024-06-30
Breast Cancer Workshop 3 - Exploring the potential of ADCs in Breast Cancer (Supported by Gilead)
09:30 - 10:30
Friday, 2024-06-28
Oncology Fellowship Masterclass
14:00 - 19:00
Lectures by this speaker
Saturday, 2024-06-29
Panel Discussion and Q&A
10:20 - 10:40
Saturday, 2024-06-29
CAPItello-291 Unlocking TRU potential for (HR)+ mBC (Satellite Symposium by AstraZeneca)
11:00 - 11:20
Saturday, 2024-06-29
Panel Discussion and Q&A
15:20 - 15:40
Saturday, 2024-06-29
Panel Discussion and Q&A
12:30 - 12:50
Saturday, 2024-06-29
Novel approach with Dual IO for the management of HCC (Satellite Symposium - BMS)
16:50 - 17:10
Saturday, 2024-06-29
Panel Discussion and Q&A
17:10 - 17:25
Saturday, 2024-06-29
S/C vs IV Anti-HER2 therapy: Preferences and Challenges
16:05 - 16:10
Saturday, 2024-06-29
Introduction: Advance Breast Cancer HR-positive: Unmet Needs
17:00 - 17:05
Sunday, 2024-06-30
Improving the Lives of Patients with mTNBC and Metastatic HR+ Breast Cancer: Safety Standpoint
10:00 - 10:10
Sunday, 2024-06-30
Debate Topic: Balancing Innovation and Safety: Navigating the Safety Seas of ADCs in Breast Cancer Treatment Clinical Scenario
10:10 - 10:30
Dr. Mariam Almarashda
Consultant Thoracic Surgeon
Tawam Hospital
United Arab Emirates
Dr. Mariam Almarashda
Consultant Thoracic Surgeon , Tawam Hospital | United Arab Emirates
Dr. Mariam Almarashda MBBS ABHS (CTh) was graduated from College of Medicine and Health Sciences, UAE University, in 2006. Finished her Arab board training in General Surgery 2013 from The General Surgery Integrated program in the Emirate of Abu Dhabi, UAE. Followed by Clinical Fellowship in Thoracic Surgery in Vanderbilt University, Tennessee, USA with clinical Research fellowship in Both Lung cancer and Oesophageal Cancer, in 2016. She was appointed as Consultant Thoracic Surgeon in SEHA in September 2016. She is Associate Professor in UAE University College of Medicine & Health Sciences. She has held several senior management role and organizer of international workshops in advanced thoracic surgical techniques including Chest wall trauma Surgery. Beside her Clinical Leadership, she has Special Interest in Medical Education, She is the Lead of ACGME- I Surgical training Program in Emirates of Abu Dhabi since 2013. Program Director of the integrated General Surgery Program since 2017. She is the Chair of Scientific committee for Surgical Programs for the NIHS Emirati board in UAE and Lead of Surveyor’s for Both NIHS Institutional and Program accreditation in the Country.
Sessions by this speaker
Sunday, 2024-06-30
Session 5: Lung Cancer
09:00 - 11:15
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
Panel Discussion and Q&A
10:25 - 10:55
Dr. Mohammed Hourani
Oncology Fellow
Tawam Hospital
United Arab Emirates
Dr. Mohammed Hourani
Oncology Fellow , Tawam Hospital | United Arab Emirates
Dr. Mohammad Hourani is a distinguished medical oncologist with an extensive background in internal medicine and oncology. He holds an MBBS degree followed by rigorous training accredited by the American Accreditation Council for Graduate Medical Education (ACGME). Dr. Hourani has earned Arab & Jordanian board in both internal medicine and medical oncology. Further enhancing his expertise, Dr. Hourani has obtained a specialty certificate in medical oncology from the United Kingdom, reflecting his commitment to maintaining a high standard of knowledge and practice in the field. Dr. Hourani is dedicated to advancing the field of oncology through both clinical practice and research. He has conducted various researches and has numerous publications under his name.
Sessions by this speaker
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
Panel Discussion and Q&A
15:20 - 15:30
Dr. Muhammad Nasim
Consultant Physician
Tawam Hospital
United Arab Emirates
Dr. Muhammad Nasim
Consultant Physician , Tawam Hospital | United Arab Emirates
Dr. Muhammad Nasim is a medical oncologist with a patient-centred approach. Throughout his oncology career, he has collaborated with multidisciplinary professionals and scientists to improve clinical outcomes for patients. His team based approach and interdisciplinary communication skills aids the smooth delivery of oncology service at this hospital. He has over 7 years’ experience as consultant Medical oncologist, having gained comprehensive site specific experience in colorectal, Gynae and Carcinoma of unknown primary (CUP), being lead for CUP, Acute Oncology and Chemotherapy subgroup, having set up CUP services at SaTH, and having managed wide variety of patients with malignancies of these tumor sites. He has represented oncology in peer review meetings for CUP and Acute oncology, and in Annual General meetings for colorectal and Gynae.
Sessions by this speaker
Saturday, 2024-06-29
Session 4: Gastrointestinal Cancers
16:00 - 17:50
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
GI Cancers Updates
15:00 - 15:10
Sunday, 2024-06-30
Panel Discussion and Q&A
15:20 - 15:30
Saturday, 2024-06-29
Panel Discussion and Q&A
17:10 - 17:25
Dr. Nouri Bennini
Consultant Oncologist
Tawam Hospital
United Arab Emirates
Dr. Nouri Bennini
Consultant Oncologist , Tawam Hospital | United Arab Emirates
Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.
Sessions by this speaker
Sunday, 2024-06-30
Session 6: Genitourinary Cancers
11:15 - 14:30
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Saturday, 2024-06-29
GU Workshop - Theranostics: The future of Prostate cancer treatment is here! (Supported by Novartis)
11:30 - 12:30
Saturday, 2024-06-29
Breast Cancer Workshop 2 - Optimizing Therapeutic Selection and Sequencing Post CDK 4/6 Inhibition (Supported by Menarini Stemline)
17:00 - 18:00
Lectures by this speaker
Sunday, 2024-06-30
Introduction
09:00 - 09:10
Sunday, 2024-06-30
Panel Discussion and Q&A
12:25 - 13:00
Sunday, 2024-06-30
Dual IO in 1L NSCLC Treatment (Satellite Symposium by BMS)
10:10 - 10:25
Saturday, 2024-06-29
EMERALD Study, Efficacy Data, Safety Profile
17:20 - 17:30
Dr. Omran El Koha
Consultant Radiation / Clinical Oncologist
Tawam Hospital
United Arab Emirates
Dr. Omran El Koha
Consultant Radiation / Clinical Oncologist , Tawam Hospital | United Arab Emirates
Dr. Omran is an experienced clinical oncologist with a demonstrated history of working in the medical and radiation oncology p . Skilled in Clinical Research, Medical Education, Strategic Planning. Strong education professional with a Master's Degree focused in Health research ethics
Sessions by this speaker
Sunday, 2024-06-30
Session 7: Practice Changing Data
14:30 - 15:35
Saturday, 2024-06-29
Tawam Faculty
09:00 - 15:30
Lectures by this speaker
Sunday, 2024-06-30
Panel Discussion and Q&A
15:20 - 15:30
Dr. Selvaraj Giridharan
Consultant Clincial Oncologist
Tawam Hospital
United Arab Emirates
Dr. Selvaraj Giridharan
Consultant Clincial Oncologist , Tawam Hospital | United Arab Emirates
Dr. Selvaraj Giridharan is a distinguished oncologist trained extensively in the UK with dual certification in radiation and medical oncology. With over 20 years of experience in tertiary and university hospital settings, he has significantly contributed to acute oncology, inpatient and outpatient care, and clinical research. Currently serving as a Consultant Medical Oncologist at Tawam Hospital, UAE, Dr. Giridharan has demonstrated exceptional skills in managing diverse patient demographics and navigating cultural nuances in cancer care. Dr Giridharan's academic journey includes a PhD and MSc in Yoga, alongside numerous certifications from prestigious institutions such as the Royal College of Radiologists, Royal College of Physicians, and European Society of Medical Oncology. His research interests are reflected in his robust publication record and active participation in clinical trials, where he has served as Principal Investigator and Sub-Investigator in over 30 randomized trials. A dedicated educator, Dr. Giridharan has held various teaching roles, including Honorary Senior Lecturer at Keele University Medical School. His leadership in multidisciplinary teams and commitment to clinical governance and quality improvement have been pivotal in enhancing healthcare outcomes. Passionate about integrating holistic approaches into cancer care, Dr. Giridharan is also deeply involved in yoga and yoga research exploring the therapeutic benefits of yoga for cancer patients, aiming to improve their quality of life and overall well-being.